Avondale Drug Patent Portfolio
Avondale owns 1 orange book drug protected by 2 US patents Given below is the list of Avondale's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6184220 | Oral suspension of pharmaceutical substance | 25 Sep, 2019 | Expired |
| US6184220 | Oral suspension of pharmaceutical substance | 25 Mar, 2019 | Expired |
Latest Legal Activities on Avondale's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Avondale.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed | 30 Jun, 2025 | US9808468 |
| Expire Patent | 23 Jun, 2025 | US9649318 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 01 Apr, 2025 | US8545879 |
| Expire Patent | 03 Feb, 2025 | US9526734 |
| Maintenance Fee Reminder Mailed | 06 Jan, 2025 | US9649318 |
| Maintenance Fee Reminder Mailed | 19 Aug, 2024 | US9526734 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 May, 2021 | US9808468 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8545879 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 16 Nov, 2020 | US9649318 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 16 Oct, 2020 | US9649318 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 29 Jun, 2020 | US9526734 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 22 May, 2020 | US9526734 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Nov, 2017 | US9808468 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Nov, 2017 | US9808468 |
|
Email Notification
Critical
| 19 Oct, 2017 | US9808468 |
Avondale's Family Patents
Avondale Drug List
Given below is the complete list of Avondale's drugs and the patents protecting them.
1. Meloxicam
Meloxicam is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6184220
(Pediatric)
| Oral suspension of pharmaceutical substance |
25 Sep, 2019
(6 years ago)
| Expired |
| US6184220 | Oral suspension of pharmaceutical substance |
25 Mar, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Meloxicam's drug page